What's on the web on your pursuit, hobbies, interests and worries

GenitalHerpes news

Vical to scrap genital herpes treatment program after trial fails primary endpoint


MarketWatch - Jun 11, 2018
Vical Inc. VICL, -26.05% said Monday a phase 2 trial of its treatment for genital herpes failed to meet its primary endpoint of annualized lesion recurrence rate. The stock was still inactive in premarket trade. In a study of 261 healthy adults with ...
 

More bad news for Vical as it abandons herpes vaccine program ...


FierceBiotech - Jun 11, 2018
The deluge of bad news reported by Vical just won't let up. The biotech confirmed today it has abandoned its lead genital herpes vaccine program after a ...
 

Vical: No Compelling Reason To Buy


Seeking Alpha - Jun 12, 2018
HSV-2 is commonly referred to as Herpes Simplex 2 and in simple terms is genital herpes. Vical has decided to enter the vaccine into phase 2 deposit not meeting top line results from its phase 1/2 trials. The company stated the following: ... Initial ...
 

Genital Herpes - premium items on eBay

Human Immunodeficiency Virus and Genital Herpes - The Deadl: The natural history


 

Human Immunodeficiency Virus And Genital Herpes - the Deadly Duo: The Natural...


 

GLIZIGEN SPRAY 60ml + GEL 250g with lactic acid GENITAL HERPES & PAPILLOMA VIRUS


 

>> Go to all great Genital Herpes deals on eBay


Genital Herpes pictures on the web

>> Show

Genital Herpes videos

Genital Herpes Myths & Facts | STDs


Watch more Learn about STDs videos: http://www.howcast.com/videos/498656-Genital-Herpes-Myths-and-Facts-STDs \
 

Describe the New Genital Herpes Therapeutic Vaccine and How it Works


Read about Herpes here: http://www.contagionlive.com/news/nih-uncovers-another-piece-to-the-puzzle-that-is-herpes Kenneth Fife, MD, PhD, Professor of ...
 

Supernatural Genital Herpes Commercial


Well... it's all in the title! Property of the CW network.
 

7A Genital Herpes


Touchpoints STD TV Commercial.
 

Genital Herpes -Gloria & Talisa


STD Project -Health class.